A new study shows that people don’t just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse – leading to questions about long-term impacts and solutions ...
ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...
North America Captures a Significant Revenue Share in the Automated Machine Learning Market, Supported by Government-Backed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback